These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7202485)

  • 1. Lack of effect of choline and narcotic antagonists upon apomorphine discrimination.
    Schechter MD
    Eur J Pharmacol; 1980 Nov; 68(2):187-91. PubMed ID: 7202485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol-induced supersensitivity to the discrimination of apomorphine.
    Schechter MD
    Eur J Pharmacol; 1981 Sep; 74(4):343-6. PubMed ID: 7297600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone as a stimulus in drug discrimination learning: generalization to other opiate antagonists.
    Smurthwaite ST; Kautz MA; Geter B; Riley AL
    Pharmacol Biochem Behav; 1992 Jan; 41(1):43-7. PubMed ID: 1539079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different dopaminergic mechanisms for amfonelic acid, amphetamine and apomorphine.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Oct; 13(4):497-500. PubMed ID: 7433481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine may mimic the apomorphine cue by inhibiting dopaminergic autoinhibition.
    Hernandez LL; Holohean AM; Appel JB
    Eur J Pharmacol; 1982 Mar; 78(3):287-94. PubMed ID: 7067729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apomorphine as a discriminative stimulus, and its antagonism by haloperidol.
    Colpaert FC; Niemegeers CJ; Kuyps JJ; Janssen PA
    Eur J Pharmacol; 1975; 32(02):383-6. PubMed ID: 1149818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors.
    Suzuki T; Mori T; Tsuji M; Misawa M; Nagase H
    Eur J Pharmacol; 1995 Sep; 284(1-2):195-8. PubMed ID: 8549626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of apomorphine's discriminative stimulus properties: relation to neuroleptic activity in neuropharmacological and biochemical assays.
    Colpaert FC; Leysen JE; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1976 Dec; 5(6):671-9. PubMed ID: 1035804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
    Weathersby RT; Appel JB
    Eur J Pharmacol; 1986 Dec; 132(1):87-91. PubMed ID: 2949989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of a low dose of apomorphine in the rat.
    Tang AH; Franklin SR
    Psychopharmacology (Berl); 1987; 91(1):61-6. PubMed ID: 3103160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narcotic antagonist potentiation of apomorphine drug effect: a stereospecific, centrally mediated drug action.
    Quock RM; Kouchich FJ; Fries DS
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(3):239-43. PubMed ID: 4041065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine potentiation of apomorphine discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Aug; 13(2):307-9. PubMed ID: 6251484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of opioid receptor ligands in rats trained to discriminate 22 from 2 hours of food deprivation suggest a lack of opioid involvement in eating for hunger.
    Jewett DC; Klockars A; Smith TR; Brunton C; Head MA; Tham RL; Kwilasz AJ; Hahn TW; Wiebelhaus JM; Ewan EE; Carroll RM; Grace MK; Levine AS; Olszewski PK
    Behav Brain Res; 2020 Feb; 380():112369. PubMed ID: 31743731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.
    White DA; Holtzman SG
    Psychopharmacology (Berl); 2003 May; 167(2):203-10. PubMed ID: 12644889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of opiates on the discriminative stimulus properties of dopamine agonists.
    Hernandez LL; Holohean AM; Appel JB
    Pharmacol Biochem Behav; 1978 Oct; 9(4):459-63. PubMed ID: 733832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptors play a role in the (-)-apomorphine-like discriminative stimulus effects of (+)-PD 128907.
    Kleven MS; Koek W
    Eur J Pharmacol; 1997 Feb; 321(1):1-4. PubMed ID: 9083778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.